We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+9.78%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$258B
AUM Growth
+$11.2B
(+4.5%)
Cap. Flow
-$8.74B
Cap. Flow
% of AUM
-3.39%
Top 10 Holdings %
Top 10 Hldgs %
19.2%
Holding
3,329
New
40
Increased
1,011
Reduced
1,986
Closed
159
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Prologis
PLD
|
+$352M |
| 2 |
Merck
MRK
|
+$333M |
| 3 |
NVIDIA
NVDA
|
+$306M |
| 4 |
Atlassian
TEAM
|
+$280M |
| 5 |
Corteva
CTVA
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$3.41B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$331M |
| 3 |
iShares Russell 1000 Growth ETF
IWF
|
+$266M |
| 4 |
Danaher
DHR
|
+$240M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$237M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.56% |
| 2 | Healthcare | 14.16% |
| 3 | Financials | 12.95% |
| 4 | Consumer Discretionary | 9.76% |
| 5 | Industrials | 9.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1301
Enova International
ENVA
$6.29B
| $13M | 0.01% |
338,532
-18,434
| -5% | -$673K |
|
1302
Gibraltar Industries
ROCK
$1.49B
| $12.9M | 0.01% |
281,467
-32,018
| -10% | -$1.54M |
|
1303
Establishment Labs
ESTA
$2.28B
| $12.9M | 0.01% |
196,678
-10,367
| -5% | -$626K |
|
1304
Central Pacific Financial
CPF
$1B
| $12.9M | 0.01% |
636,290
+62,024
| +11% | +$1.27M |
|
1305
James River Group Holdings
JRVR
$217M
| $12.9M | 0.01% |
616,864
-10,852
| -2% | -$249K |
|
1306
Ingredion
INGR
$6.58B
| $12.9M | 0.01% |
131,552
-5,877
| -4% | -$542K |
|
1307
Lyft
LYFT
$6.63B
| $12.9M | 0.01% |
1,167,625
-9,573
| -0.8% | -$115K |
|
|
CSR
1308
Centerspace
CSR
$952M
| $12.9M | 0.01% |
219,214
-44,858
| -17% | -$2.9M |
|
1309
First Busey Corp
BUSE
$2.56B
| $12.9M | 0.01% |
520,023
+31,500
| +6% | +$789K |
|
1310
ATI
ATI
$31B
| $12.9M | 0.01% |
430,420
-5,354
| -1% | -$157K |
|
1311
State Street SPDR Bloomberg High Yield Bond ETF
JNK
$6.92B
| $12.8M | 0.01% |
+142,606
| New | +$12.9M |
|
1312
Rayonier
RYN
$6.55B
| $12.7M | ﹤0.01% |
426,265
-4,876
| -1% | -$150K |
|
|
NARI
1313
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $12.7M | ﹤0.01% |
200,520
+36,077
| +22% | +$2.62M |
|
1314
Blackstone Mortgage Trust
BXMT
$2.38B
| $12.7M | ﹤0.01% |
600,385
-311,534
| -34% | -$7.38M |
|
1315
PENN Entertainment
PENN
$2.71B
| $12.7M | ﹤0.01% |
427,418
-8,775
| -2% | -$285K |
|
1316
Virtu Financial
VIRT
$4.93B
| $12.7M | ﹤0.01% |
621,777
+62,084
| +11% | +$1.35M |
|
1317
State Street SPDR S&P Biotech ETF
XBI
$10.3B
| $12.7M | ﹤0.01% |
152,792
+99,163
| +185% | +$8.03M |
|
1318
Robinhood
HOOD
$83.9B
| $12.7M | ﹤0.01% |
1,555,793
+109,664
| +8% | +$1.08M |
|
1319
ESAB
ESAB
$5.71B
| $12.7M | ﹤0.01% |
269,695
+152,415
| +130% | +$6.38M |
|
|
LTHM
1320
DELISTED
Livent Corporation
LTHM
| $12.6M | ﹤0.01% |
636,469
-216,836
| -25% | -$5.93M |
|
1321
Axcelis
ACLS
$4.33B
| $12.6M | ﹤0.01% |
159,121
+40,718
| +34% | +$2.87M |
|
1322
Lumentum
LITE
$69.3B
| $12.6M | ﹤0.01% |
241,981
-646,036
| -73% | -$39.7M |
|
1323
Mativ Holdings
MATV
$711M
| $12.6M | ﹤0.01% |
604,050
-48,646
| -7% | -$1.05M |
|
|
GMS
1324
DELISTED
GMS Inc
GMS
| $12.6M | ﹤0.01% |
252,099
+45,980
| +22% | +$2.2M |
|
1325
Xerox
XRX
$425M
| $12.5M | ﹤0.01% |
856,925
-141,546
| -14% | -$2.13M |
|
Similar funds
VFT
Nuveen's Q4 2022 Portfolio in Review
As of Q4 2022, Nuveen held 3,329 positions worth $258B, up 4.5% from $247B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Nuveen withdrew a net $8.74B in Q4 2022, closing 159 positions and reducing 1,986 holdings. Its most notable exit was Twitter, Inc., an estimated $237M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Nuveen opened a new position in Atlassian worth $226M.
- Nuveen's largest Q4 2022 buy was Atlassian: 1,759,716 shares worth $226M.
- Nuveen added most to Prologis in Q4 2022, an estimated $352M increase.
- Nuveen's biggest Q4 2022 reduction was Alnylam Pharmaceuticals, cutting an estimated $3.41B.
- Nuveen fully exited Twitter, Inc. in Q4 2022, selling an estimated $237M.
- Nuveen's ten largest holdings make up 19% of its $258B portfolio in Q4 2022.
- Nuveen opened 40 new positions and closed 159 in Q4 2022.
- Nuveen's portfolio value rose 4.5% quarter-over-quarter to $258B.
Based on Nuveen's 13F filing for Q4 2022, filed 14 Feb 2023.